Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 5/20 | 0.36 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.36 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21972257 | 0.91 | LMNA (0.49) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL21972266 | 0.91 | LMNA (0.49) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL21972265 | 0.88 | LMNA (0.46) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL21971404 | 0.85 | LMNA (0.58) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL20739824 | 0.84 | LMNA (0.36) | LMNAPDGFRBKDM4EALDH1A1GLA | |
| SCHEMBL20739823 | 0.84 | LMNA (0.50) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL20739683 | 0.84 | LMNA (0.37) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL21972251 | 0.82 | LMNA (0.49) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL20739761 | 0.82 | CRHR1 (0.36) | LMNAPDGFRBMEN1KMT2AKDM4E | |
| SCHEMBL21971009 | 0.82 | LMNA (0.63) | LMNAPDGFRBMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046655-B2 | Compound and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-29 | — | — | US | disclosed |
| EP-3416205-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | disclosed |
| US-10711091-B2 | Light-emitting device and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20200140394-A1 | NOVEL COMPOUND AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-07 | — | — | US | disclosed |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711091-B2 | Light-emitting device and method for producing same | SCO2, SUN2, SLC18A2 | LMNA 919/4885PDGFRB 4805/4885MEN1 2564/4885 |
| US-20200140394-A1 | NOVEL COMPOUND AND METHOD FOR PRODUCING SAME | CBR3, NR2E3, NR5A2 | LMNA 4733/4885PDGFRB 2517/4885MEN1 1897/4885 |
| US-20190048131-A1 | LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME | SCO2, SUN2, SLC18A2 | LMNA 919/4885PDGFRB 4805/4885MEN1 2564/4885 |
| US-11046655-B2 | Compound and method for producing same | CBR3, NR5A1, NR2E3 | LMNA 4570/4885PDGFRB 2499/4885MEN1 1027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.